%20(2).png){kind=logo}
Leverage intimate and high-value interactions with influential leaders while discussing and engaging in the most pressing topics to leave with actionable strategies that innovate and increase overall marketing effectiveness.
Visit Ostro at Booth #4 and join Ostro's Head of Product, Gurjeev Singh, to learn how to transform every touchpoint with AI-powered orchestration.
TrumpRx may reshape U.S. drug access—Pfizer leads the way as experts weigh cost savings, transparency, and the impact on patients, insurers, and pharma.
Verily’s ex-chief commercial officer sued the healthtech company for wrongful employment, citing HIPAA violations.
MM+M’s latest eBook explores how pharma brands can embrace AI to engage HCPs more effectively and become trusted partners by delivering relevant and meaningful content dynamically.
The U.S. will impose 100% tariffs on imported branded drugs from Oct. 1, 2025, exempting firms with U.S. projects. Pharma must localize, pursue deals, and manage unclear exemption rules.
Watch a live demo of Ostro’s AI agents transforming how pharma brands engage patients and HCPs—delivering PRC-compliant, dynamic conversations via tailored email and SMS experiences.
A global pharma brand used Ostro Tailor to personalize oncology websites, boosting rep engagement, resource access, and HCP conversions.
The unified digital platform helps providers and patients access clear, compliant, and personalized pharmaceutical information with AI-powered tools.
.svg)